Cargando…
Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
BACKGROUND: The purpose of this study was to clarify the prevalence, association with frailty and exercise capacity, and prognostic implication of sarcopenic obesity in patients with heart failure. METHODS: The present study included 779 older adults hospitalized with heart failure (median age: 81 y...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254413/ https://www.ncbi.nlm.nih.gov/pubmed/35787667 http://dx.doi.org/10.1186/s12877-022-03168-3 |
_version_ | 1784740693532475392 |
---|---|
author | Saito, Hiroshi Matsue, Yuya Kamiya, Kentaro Kagiyama, Nobuyuki Maeda, Daichi Endo, Yoshiko Ueno, Hidenao Yoshioka, Kenji Mizukami, Akira Saito, Kazuya Ogasahara, Yuki Maekawa, Emi Konishi, Masaaki Kitai, Takeshi Iwata, Kentaro Jujo, Kentaro Wada, Hiroshi Hiki, Masaru Dotare, Taishi Sunayama, Tsutomu Kasai, Takatoshi Nagamatsu, Hirofumi Ozawa, Tetsuya Izawa, Katsuya Yamamoto, Shuhei Aizawa, Naoki Wakaume, Kazuki Oka, Kazuhiro Momomura, Shin-ichi Minamino, Tohru |
author_facet | Saito, Hiroshi Matsue, Yuya Kamiya, Kentaro Kagiyama, Nobuyuki Maeda, Daichi Endo, Yoshiko Ueno, Hidenao Yoshioka, Kenji Mizukami, Akira Saito, Kazuya Ogasahara, Yuki Maekawa, Emi Konishi, Masaaki Kitai, Takeshi Iwata, Kentaro Jujo, Kentaro Wada, Hiroshi Hiki, Masaru Dotare, Taishi Sunayama, Tsutomu Kasai, Takatoshi Nagamatsu, Hirofumi Ozawa, Tetsuya Izawa, Katsuya Yamamoto, Shuhei Aizawa, Naoki Wakaume, Kazuki Oka, Kazuhiro Momomura, Shin-ichi Minamino, Tohru |
author_sort | Saito, Hiroshi |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to clarify the prevalence, association with frailty and exercise capacity, and prognostic implication of sarcopenic obesity in patients with heart failure. METHODS: The present study included 779 older adults hospitalized with heart failure (median age: 81 years; 57.4% men). Sarcopenia was diagnosed based on the guidelines by the Asian Working Group for Sarcopenia. Obesity was defined as the percentage of body fat mass (FM) obtained by bioelectrical impedance analysis. The FM cut-off points for obesity were 38% for women and 27% for men. The primary endpoint was 1-year all-cause death. We assessed the associations of sarcopenic obesity occurrence with the short physical performance battery (SPPB) score and 6-minute walk distance (6MWD). RESULTS: The rates of sarcopenia and obesity were 19.3 and 26.2%, respectively. The patients were classified into the following groups: non-sarcopenia/non-obesity (58.5%), non-sarcopenia/obesity (22.2%), sarcopenia/non-obesity (15.3%), and sarcopenia/obesity (4.0%). The sarcopenia/obesity group had a lower SPPB score and shorter 6MWD, which was independent of age and sex (coefficient, − 0.120; t-value, − 3.74; P < 0.001 and coefficient, − 77.42; t-value, − 3.61; P < 0.001; respectively). Ninety-six patients died during the 1-year follow-up period. In a Cox proportional hazard analysis, sarcopenia and obesity together were an independent prognostic factor even after adjusting for a coexisting prognostic factor (non-sarcopenia/non-obesity vs. sarcopenia/obesity: hazard ratio, 2.48; 95% confidence interval, 1.22–5.04; P = 0.012). CONCLUSION: Sarcopenic obesity is a risk factor for all-cause death and low physical function in older adults with heart failure. TRIAL REGISTRATION: University Hospital Information Network (UMIN-CTR: UMIN000023929). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-03168-3. |
format | Online Article Text |
id | pubmed-9254413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92544132022-07-06 Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF Saito, Hiroshi Matsue, Yuya Kamiya, Kentaro Kagiyama, Nobuyuki Maeda, Daichi Endo, Yoshiko Ueno, Hidenao Yoshioka, Kenji Mizukami, Akira Saito, Kazuya Ogasahara, Yuki Maekawa, Emi Konishi, Masaaki Kitai, Takeshi Iwata, Kentaro Jujo, Kentaro Wada, Hiroshi Hiki, Masaru Dotare, Taishi Sunayama, Tsutomu Kasai, Takatoshi Nagamatsu, Hirofumi Ozawa, Tetsuya Izawa, Katsuya Yamamoto, Shuhei Aizawa, Naoki Wakaume, Kazuki Oka, Kazuhiro Momomura, Shin-ichi Minamino, Tohru BMC Geriatr Research BACKGROUND: The purpose of this study was to clarify the prevalence, association with frailty and exercise capacity, and prognostic implication of sarcopenic obesity in patients with heart failure. METHODS: The present study included 779 older adults hospitalized with heart failure (median age: 81 years; 57.4% men). Sarcopenia was diagnosed based on the guidelines by the Asian Working Group for Sarcopenia. Obesity was defined as the percentage of body fat mass (FM) obtained by bioelectrical impedance analysis. The FM cut-off points for obesity were 38% for women and 27% for men. The primary endpoint was 1-year all-cause death. We assessed the associations of sarcopenic obesity occurrence with the short physical performance battery (SPPB) score and 6-minute walk distance (6MWD). RESULTS: The rates of sarcopenia and obesity were 19.3 and 26.2%, respectively. The patients were classified into the following groups: non-sarcopenia/non-obesity (58.5%), non-sarcopenia/obesity (22.2%), sarcopenia/non-obesity (15.3%), and sarcopenia/obesity (4.0%). The sarcopenia/obesity group had a lower SPPB score and shorter 6MWD, which was independent of age and sex (coefficient, − 0.120; t-value, − 3.74; P < 0.001 and coefficient, − 77.42; t-value, − 3.61; P < 0.001; respectively). Ninety-six patients died during the 1-year follow-up period. In a Cox proportional hazard analysis, sarcopenia and obesity together were an independent prognostic factor even after adjusting for a coexisting prognostic factor (non-sarcopenia/non-obesity vs. sarcopenia/obesity: hazard ratio, 2.48; 95% confidence interval, 1.22–5.04; P = 0.012). CONCLUSION: Sarcopenic obesity is a risk factor for all-cause death and low physical function in older adults with heart failure. TRIAL REGISTRATION: University Hospital Information Network (UMIN-CTR: UMIN000023929). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-03168-3. BioMed Central 2022-07-05 /pmc/articles/PMC9254413/ /pubmed/35787667 http://dx.doi.org/10.1186/s12877-022-03168-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Saito, Hiroshi Matsue, Yuya Kamiya, Kentaro Kagiyama, Nobuyuki Maeda, Daichi Endo, Yoshiko Ueno, Hidenao Yoshioka, Kenji Mizukami, Akira Saito, Kazuya Ogasahara, Yuki Maekawa, Emi Konishi, Masaaki Kitai, Takeshi Iwata, Kentaro Jujo, Kentaro Wada, Hiroshi Hiki, Masaru Dotare, Taishi Sunayama, Tsutomu Kasai, Takatoshi Nagamatsu, Hirofumi Ozawa, Tetsuya Izawa, Katsuya Yamamoto, Shuhei Aizawa, Naoki Wakaume, Kazuki Oka, Kazuhiro Momomura, Shin-ichi Minamino, Tohru Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF |
title | Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF |
title_full | Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF |
title_fullStr | Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF |
title_full_unstemmed | Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF |
title_short | Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF |
title_sort | sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from fragile-hf |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254413/ https://www.ncbi.nlm.nih.gov/pubmed/35787667 http://dx.doi.org/10.1186/s12877-022-03168-3 |
work_keys_str_mv | AT saitohiroshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT matsueyuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT kamiyakentaro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT kagiyamanobuyuki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT maedadaichi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT endoyoshiko sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT uenohidenao sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT yoshiokakenji sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT mizukamiakira sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT saitokazuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT ogasaharayuki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT maekawaemi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT konishimasaaki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT kitaitakeshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT iwatakentaro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT jujokentaro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT wadahiroshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT hikimasaru sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT dotaretaishi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT sunayamatsutomu sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT kasaitakatoshi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT nagamatsuhirofumi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT ozawatetsuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT izawakatsuya sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT yamamotoshuhei sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT aizawanaoki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT wakaumekazuki sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT okakazuhiro sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT momomurashinichi sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf AT minaminotohru sarcopenicobesityisassociatedwithimpairedphysicalfunctionandmortalityinolderpatientswithheartfailureinsightfromfragilehf |